Normal immunoglobulin human 20g/200ml solution for infusion bottles
NHS hospitals in England used £128,023,340 of indicative cost of Normal immunoglobulin human 20g/200ml solution for infusion bottles in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 211.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Normal immunoglobulin human 20g/200ml solution for infusion bottles: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Normal immunoglobulin human 20g/200ml solution for infusion bottles most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £7,736,280 |
| University College London Foundation Tr | £7,228,440 |
| Salford Royal Nhs Foundation Trust | £6,385,260 |
| Leeds Teaching Hpls Nhs Trust | £5,303,340 |
| Royal Free London Nhs Foundation Trust | £4,886,580 |
| Barts Health Nhs Trust | £4,580,220 |
| Sheffield Teaching Hospitals Nhs Trust | £4,416,000 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,823,980 |
| King's College Hpl Nhs Foundation Trust | £3,677,700 |
| St George's Univ Hosps Foundation Nhst | £3,465,180 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.